It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The grading system for ultrasonographic assessment of Schistosoma mansoni morbidity is crucial for evaluation of control programs. This requires prior definition of normal liver organometric ranges in the population from the endemic area. A cross-sectional study was conducted in a S. mansoni endemic area in rural Cameroon. 1002 Participants were screened and 234 of them, free from all common liver-affecting diseases in the area (schistosomiasis, malaria, hepatitis B and C) and with no ultrasonographic signs of liver disease were selected and their liver parameters measured by ultrasonography. All statistics were considered significant for p-values < 0.05. Normal dimensions of livers lobe sizes, portal vein wall thickness and portal vein diameters are reported. The liver organometric data are presented for the entire study population as a whole and separately for males and females as prediction plots, with observed values and fitted regression line with 95% confidence. Reference ranges for liver parameters (size, portal vein thickness and diameter) adjusted for body height established in the current study are novel for Cameroon. The prediction plots generated should improve the accuracy of the assessment of liver morbidity by ultrasonography in the region.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa (GRID:grid.7836.a) (ISNI:0000 0004 1937 1151); Cape Town Component, International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa (GRID:grid.443877.b); Immunology of Infectious Diseases Unit, South African Medical Research Centre, Cape Town, South Africa (GRID:grid.443877.b)
2 School of Health Sciences, Catholic University of Central Africa, Yaoundé, Cameroon (GRID:grid.442755.5)
3 School of Health Sciences, Catholic University of Central Africa, Yaoundé, Cameroon (GRID:grid.442755.5); CIAB EXACT Medical Laboratory, Yaoundé, Cameroon (GRID:grid.442755.5)
4 Faculty of medicine and biomedical sciences, University of Yaoundé 1, Yaoundé, Cameroon (GRID:grid.412661.6) (ISNI:0000 0001 2173 8504)
5 Ministry of Public health, Yaoundé, Cameroon (GRID:grid.415857.a) (ISNI:0000 0001 0668 6654)
6 School of Health Sciences, Catholic University of Central Africa, Yaoundé, Cameroon (GRID:grid.442755.5); National Public Health Laboratory, Ministry of Public Health, Yaoundé, Cameroon (GRID:grid.415857.a) (ISNI:0000 0001 0668 6654)
7 National Public Health Laboratory, Ministry of Public Health, Yaoundé, Cameroon (GRID:grid.415857.a) (ISNI:0000 0001 0668 6654)
8 Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa (GRID:grid.7836.a) (ISNI:0000 0004 1937 1151); Cape Town Component, International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa (GRID:grid.443877.b); Immunology of Infectious Diseases Unit, South African Medical Research Centre, Cape Town, South Africa (GRID:grid.443877.b); Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa (GRID:grid.497864.0)
9 Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa (GRID:grid.7836.a) (ISNI:0000 0004 1937 1151); Cape Town Component, International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa (GRID:grid.443877.b); Immunology of Infectious Diseases Unit, South African Medical Research Centre, Cape Town, South Africa (GRID:grid.443877.b); The Medical Research Centre, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation, Yaoundé, Cameroon (GRID:grid.500526.4) (ISNI:0000 0004 0595 6917)